Circulatory assistance with a cardiac allograft after exclusion of the canine left ventricle
Related Experiment Videos
Insights
This study explores a novel left ventricular assist device for cardiogenic shock post-myocardial infarction. The experimental model demonstrated potential for supporting circulation and salvaging heart muscle.
Area of Science:
- Cardiovascular Surgery
- Experimental Medicine
- Cardiac Physiology
Background:
- Cardiogenic shock following myocardial infarction has high mortality rates.
- Current treatments like intra-aortic balloon pumps and revascularization have limitations.
Purpose of the Study:
- To develop and test an experimental left ventricular assist device for cardiogenic shock.
- To evaluate the potential of this device to support circulation and improve outcomes after myocardial infarction.
Main Methods:
- An experimental canine model was created using mitral valve closure and an interpositional cardiac allograft.
- This preparation served as a left ventricular assist device, supporting circulation after cardiopulmonary bypass.
Main Results:
- The cardiac allograft successfully supported recipient circulation in 25 animals.
- Survival was sustained for 1 to 32 days in 16 dogs utilizing the assist device.
Conclusions:
- This left ventricular assistance method shows promise for treating cardiogenic shock post-myocardial infarction.
- Maximal left ventricular decompression and improved coronary perfusion may salvage viable myocardium and reverse metabolic imbalances.
Abstract:
Cardiogenic shock after myocardial infarction still carries a high mortality despite use of intraaortic counterpulsation and early surgical revascularization. An experimental canine model of left ventricular exclusion and circulation support was developed by closing the mitral valve and by interposing "in series" a cardiac allograft between pulmonary and systemic circulations. This preparation was able to support the recipient circulation after cardiopulmonary bypass in 25 animals. In 16 dogs the graft sustained life for from 1 to 32 days. It is hypothesized that such left ventricular assistance could be used to maintain the life of patients in cardiogenic shock after myocardial infarction. By providing maximal left ventricular decompression and improvement of the native coronary perfusion, this method may reverse the metabolic imbalance responsible for extension of the infarction, thereby salvaging muscle that is in jeopardy but still viable.